• 1. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 2. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 3. Aluminium complexes with thio-phosphorus ligands: syntheses and characterisations of [Al2(CyPS3)2(CyPHS2)2] and [Al(S2PPh2)3]?
  Robert P. Davies,Maria A. Giménez,Laura Patel,Andrew J. P. White Dalton Trans., 2008, 5705-5707
• 4. Alt-proteins: A promising future
• 5. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877

Ethyl 2-(4-methylphenyl)pyrimidine-5-carboxylate (CAS No. 65586-64-3): A Comprehensive Overview

Ethyl 2-(4-methylphenyl)pyrimidine-5-carboxylate, identified by its Chemical Abstracts Service (CAS) number 65586-64-3, is a significant compound in the realm of pharmaceutical chemistry. This compound belongs to the pyrimidine class, which is well-documented for its diverse biological activities and pharmacological applications. The structural integrity of this molecule, featuring an ethyl ester group at the 5-position and a 4-methylphenyl substituent at the 2-position, contributes to its unique chemical properties and potential therapeutic benefits.

The Ethyl 2-(4-methylphenyl)pyrimidine-5-carboxylate molecule has garnered attention in recent years due to its role as a key intermediate in the synthesis of various pharmacologically active agents. Pyrimidine derivatives are extensively studied for their antimicrobial, antiviral, and anticancer properties. The presence of the methylphenyl group enhances the lipophilicity of the compound, making it more suitable for membrane permeability and subsequent cellular uptake. This feature is particularly crucial in drug design, where optimizing bioavailability is a primary objective.

Recent advancements in medicinal chemistry have highlighted the importance of pyrimidine-based compounds in developing novel therapeutic agents. For instance, studies have demonstrated that modifications in the pyrimidine ring can significantly alter the biological activity of these molecules. The ethyl ester functionality at the 5-position provides a versatile site for further chemical modifications, enabling the synthesis of more complex derivatives with enhanced pharmacological properties.

In the context of oncology research, Ethyl 2-(4-methylphenyl)pyrimidine-5-carboxylate has been investigated for its potential as an anti-proliferative agent. Preliminary studies suggest that this compound can interfere with critical cellular pathways involved in cancer cell growth and survival. Specifically, it has shown promise in inhibiting kinases and other enzymes that are overexpressed in various types of cancer. These findings align with the broader trend in oncology research, where targeting aberrant signaling pathways is a key strategy for developing effective anti-cancer therapies.

The structural features of Ethyl 2-(4-methylphenyl)pyrimidine-5-carboxylate also make it an attractive candidate for further derivatization to enhance its pharmacokinetic profile. For example, incorporating additional functional groups can improve solubility, reduce toxicity, and increase metabolic stability. Such modifications are essential for translating preclinical findings into clinical applications. Researchers are exploring various synthetic routes to optimize the production of this compound while maintaining its biological efficacy.

Another area of interest is the antimicrobial potential of Ethyl 2-(4-methylphenyl)pyrimidine-5-carboxylate. Antimicrobial resistance remains a significant global health challenge, necessitating the development of new antibiotics and anti-fungal agents. Pyrimidine derivatives have shown promise in this regard due to their ability to disrupt microbial cell wall synthesis and other vital processes. The unique structural motifs present in this compound may offer novel mechanisms of action against resistant strains of bacteria and fungi.

The synthesis of Ethyl 2-(4-methylphenyl)pyrimidine-5-carboxylate involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Advanced synthetic methodologies, such as catalytic hydrogenation and palladium-catalyzed cross-coupling reactions, have been employed to streamline the process. These techniques not only improve efficiency but also minimize unwanted byproducts, making the synthesis more sustainable and environmentally friendly.

In conclusion, Ethyl 2-(4-methylphenyl)pyrimidine-5-carboxylate (CAS No. 65586-64-3) is a multifaceted compound with significant potential in pharmaceutical research. Its unique structural features and biological activities make it a valuable intermediate for developing novel therapeutic agents. Ongoing research efforts are focused on optimizing its synthesis and exploring its pharmacological applications in oncology and antimicrobial therapy. As our understanding of molecular mechanisms continues to evolve, compounds like Ethyl 2-(4-methylphenyl)pyrimidine-5-carboxylate will play an increasingly important role in addressing global health challenges.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)